Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

Journal of Neural Transmission

Volumn 111, Issue 12, 2004, Pages 1543-1573

  Grunblatt E ^a   Mandel, S ^b   Jacob Hirsch, J ^c   Zeligson, S ^c   Amariglo, N ^c   Rechavi, G ^c   Li, J ^a   Ravid, R ^d   Roggendorf, W ^a   Riederer, P ^a   Youdim, M B H ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Affymetrix; Cerebellum; Gene expression; HSC70; Iron; Parkinson's disease; Quantitative real time PCR; SKP1A; Substantia nigra pars compacta; Ubiquitin proteasome system

Indexed keywords

HEAT SHOCK PROTEIN; IRON; PROTEASOME; PROTEIN; SKP1A PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOSKELETON; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; ION TRANSPORT; METABOLISM; NUCLEOTIDE SEQUENCE; PARKINSONISM; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; UBIQUITINATION;

EID: 19944428747     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0212-1     Document Type: Article

References (89)

1. Agid Y, Javoy F, Youdim MBH (1973) Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway. Br J Pharmacol 48(1): 175-178
2. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295(5556): 865-868
3. Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH (2001) Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(1S)F]FDG-PET. Mov Disord 16(6): 1014-1022
4. Blencowe BJ, Bauren G, Eldridge AG, Issner R, Nickerson JA, Rosonina E, Sharp PA (2000) The SRm160/300 splicing coactivator subunits. RNA 6(1): 111-120
5. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299(5604): 256-259
6. Bonini NM (2002) Chaperoning brain degeneration. PNAS 99(90004): 16407-16411
7. Braak H, Braak E (1997) Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 18 [Suppl 4]: S85-S88
8. Brooks DJ (2003) Imaging end points for monitoring neuroprotection in Parkinson's disease. Ann Neurol 53 [Suppl 3]: S110-S118; discussion S118-S119
9. Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40(2): 427-446
10. Cohlberg JA, Li J, Uversky VN, Fink AL (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41(5): 1502-1511
11. Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M (2001) Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci 24(1): 25-31
12. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 26S and 26S proteasomes. Annu Rev Biochem 65: 801-847
13. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39(6): 889-909
14. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302(5646): 819-822
15. De Ferrari GV, Inestrosa NC (2000) Wnt signaling function in Alzheimer's disease. Brain Res Rev 33(1): 1-12
16. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4(5): P3
17. Dev KK, van der Putten H, Sommer B, Rovelli G (2003) Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology 45(1): 1-13
18. Duncan RJ, Sourkes TL, Boucher R, Poirier LJ, Roberge A (1972) Aldehyde dehydrogenase and monoamine oxidase in the striatum of cats with nigrostriatal lesions. J Neurochem 19(8): 2007-2010
19. Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J (2001) Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease. Biol Signals Recept 10(3-4): 224-253
20. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1): 43-54
21. Felletschin B, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Sommer U, Zeiler B, Becker G, Riess O, Berg D (2003) Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett 352(1): 53-56
22. Futatsumori M, Kasai K, Takatsu H, Shin HW, Nakayama K (2000) Identification and characterization of novel isoforms of COP I subunits. J Biochem 128(5): 793-801
23. Galter D, Buervenich S, Carmine A, Anvret M, Olson L (2003) ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis 14(3): 637-647
24. Ghee M, Fournier A, Mallet J (2000) Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex. J Neurochem 75(5): 2221-2224
25. Ghislain M, Udvardy A, Mann C (1993) S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase. Nature 366(6453): 358-362
26. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82(2): 373-428
27. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D (1998) A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94(5): 615-623
28. Gonzalez L Jr, Scheller RH (1999) Regulation of membrane trafficking: structural insights from a Rab/effector complex. Cell 96(6): 755-758
29. Gordon C, McGurk G, Dillon P, Rosen C, Hastie ND (1993) Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit. Nature 366(6453): 355-357
30. Götz ME, Kunig G, Riederer P, Youdim MB (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63(1): 37-122
31. Grünblatt E, Mandel S, Maor G, Youdim MBH (2001) Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. J Neurochem 78(1): 1-12
32. Hanson ES, Rawlins ML, Leibold EA (2003) Oxygen and iron regulation of iron regulatory protein 2. J Biol Chem 278(41): 40337-40342
33. Harrington KA, Augood SJ, Kingsbury AE, Foster OJ, Emson PC (1996) Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease. Brain Res Mol Brain Res 36(1): 157-162
34. Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E (2004) Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease. J Biol Chem 279(22): 23622-23629
35. Hay JC, Hirling H, Scheller RH (1996) Mammalian vesicle trafficking proteins of the endoplasmic reticulum and Golgi apparatus. J Biol Chem 271(10): 5671-5679
36. Hjelle JJ, Petersen DR (1983) Hepatic aldehyde dehydrogenases and lipid peroxidation. Pharmacol Biochem Behav 18 [Suppl 1]: 155-160
37. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5): 427-442
38. Hosack D, Dennis G, Sherman B, Lane H, Lempicki R (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4(10): R70
39. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI, Takahashi R (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 10(1): 55-67
40. Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18 [Suppl 6]: S2-S12
41. Jenner P (1998) Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord [Suppl 13]: 24-34
42. Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47[6 Suppl 3]: S161-S170
43. Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin WG Jr, Elledge SJ, Conaway RC, Harper JW, Conaway JW (1999) Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284(5414): 657-661
44. Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 279(24): 25497-25502
45. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller G, Abu-Asab M, Tsokos M, Switzer R, 3rd, Grinberg A, Love P, Tresser N, Rouault TA (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27(2): 209-214
46. Lee JW, Bae SH, Jeong J, Kim SH, Kim KW (2004) Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 29;36(1):1-12
47. Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S (2004) Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci USA 101(15): 5500-5505
48. Lukiw WJ, Bazan NG (1997) Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 50(6): 937-945
49. Mardh G, Vallee BL (1986) Human class I alcohol dehydrogenases catalyze the interconversion of alcohols and aldehydes in the metabolism of dopamine. Biochemistry 25(23): 7279-7282
50. Marx FP, Berg D, Dawson S, Riess O, Schultz JB, Krueger R (2004) Parkinson's disease-associated mutant synphilin-1 mediates proteasomal inhibition and interacts with regulatory proteasomal protein S6. Mov Disord 19 [Suppl 9]: S83
51. McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci Lett 326(3): 155-158
52. McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179(1): 38-46
53. Meredith GE, Halliday GM, Totterdell S (2004) A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation. Parkinsonism Relat Disord 10(4): 191-202
54. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, Berger UV, Land W, Ollivierre-Wilson H, Grinberg A, Love P, Rouault TA (2004) Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23(2): 386-395
55. Minchenko O, Opentanova I, Caro J (2003) Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 554(3): 264-270
56. Murata S, Chiba T, Tanaka K (2003) CHIP: a quality-control E3 ligase collaborating with molecular chaperones. Int J Biochem Cell Biol 35(5): 572-578
57. Olanow CW, Youdim MB (1996) Iron and neurodegeneration: prospects for neuroprotection. In: Olanow CW, Jenner P, Youdim MB (eds) Neurodegeneration and neuroprotection in Parkinson's disease. Academic Press, London, pp 55-69
58. Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20(16): 6048-6054
59. Ouimet CC, Hemmings HC Jr, Greengard P (1989) ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain. J Neurosci 9(3): 865-875
60. Padmanabhan J, Park DS, Greene LA, Shelanski ML (1999) Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J Neurosci 19(20): 8747-8756
61. Ponka P (2004) Hereditary causes of disturbed iron homeostasis in the central nervous system. Ann NY Acad Sci 1012: 267-281
62. Ribeiro CS, Carneiro K, Ross CA, Menezes JR, Engelender S (2002) Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J Biol Chem 277(26): 23927-23933
63. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52(2): 515-520
64. Schulz H, Weber B, Wiedmann C (2004) Quantitative real-time PCR - eine Frage der Normalisierung. BIO Spektrum 1: 99-101
65. Semple CA (2003) The comparative proteomics of ubiquitination in mouse. Genome Res 13(6B): 1389-1394
66. Sherman MY, Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29(1): 15-32
67. Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B (2003) Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem 278(14): 11753-11759
68. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37(5): 735-749
69. Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8(5): 731-741
70. Strickland E, Hakala K, Thomas PJ, DeMartino GN (2000) Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26S proteasome. J Biol Chem 275(8): 5565-5572
71. Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA, Milbrandt J (2000) EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 275(49): 38524-38531
72. Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279(6): 4625-4631
73. Tsou K, Girault JA, Greengard P (1993) Dopamine Dl agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantia nigra. J Neurochem 60(3): 1043-1046
74. Tsukahara F, Yoshioka T, Muraki T (2000) Molecular and functional characterization of HSC54, a novel variant of human heat-shock cognate protein 70. Mol Pharmacol 58(6): 1257-1263
75. Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D (2001) alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radie Biol Med 30(10): 1163-1170
76. Ugozzoli LA, Chinn D, Hamby K (2002) Fluorescent multicolor multiplex homogeneous assay for the simultaneous analysis of the two most common hemochromatosis mutations. Anal Biochem 307(1): 47-53
77. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7): RESEARCH0034
78. Verdaguer E, Garcia-Jorda E, Canudas AM, Dominguez E, Jimenez A, Pubill D, Escubedo E, Pallas JC, Camins A (2002) Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry. Neuroreport 13(4): 413-416
79. Voges D, Zwickl P, Baumeister W (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68: 1015-1068
80. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol 47(4): 521-523
81. Wang HY, Lin W, Dyck JA, Yeakley JM, Songyang Z, Cantley LC, Fu XD (1998) SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol 140(4): 737-750
82. Wang J, Chen G, Muckenthaler M, Galy B, Hentze MW, Pantopoulos K (2004) Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol Cell Biol 24(3): 954-965
83. Wendler F, Tooze S (2001) Syntaxin 6: the promiscuous behaviour of a SNARE protein. Traffic 2(9): 606-611
84. Wu YR, Wang CK, Chen CM, Hsu Y, Lin SJ, Lin YY, Fung HC, Chang KH, Lee-Chen GJ (2004) Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease. Hum Genet 114(3): 236-241
85. Youdim MB, Ben-Shachar D, Riederer P (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov Disord 8(1): 1-12
86. Youdim MBH, Riederer P (1997) Understanding Parkinson's disease. Sci Am 276(1): 52-59
87. Youdim MBH, Riederer P (2004) Iron in the brain, normal and pathological. In: Adelman G, Smith B (eds) Encyclopedia of neuroscience, 3rd edn. Elsevier, Amsterdam
88. Zhang J, Goodlett DR (2004) Proteomic approach to studying Parkinson's disease. Mol Neurobiol 29(3): 271-288
89. Zinsmaier KE, Bronk P (2001) Molecular chaperones and the regulation of neurotransmitter exocytosis. Biochem Pharmacol 62(1): 1-11